FEMA Mitigation Best Practices: Biotechnology Company Implements Seismic Safety   [open pdf - 28KB]

Alternate Title: Biotechnology Company Uses Safety Genentech Seismic Upgrades

This document is part of the Federal Emergency Management Agency (FEMA) Best Practices Portfolio. The Best Practices Portfolio is a collection of true stories about people and communities who have experienced disasters, and what mitigation they used to survive, rebuild, and prepare for disasters. From the document: "Genentech, Inc., is a leading biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals for significant unmet medical needs. Twelve of the currently marketed biotechnology products stem from Genentech science. Science at Genentech focuses primarily on three areas of medicine: cardiovascular, oncology and endocrinology. To protect their employees and reduce business interruptions in the event of a natural disaster, Genentech has developed a comprehensive disaster preparedness program. The program includes the establishment of a fully trained and supplied emergency response team and the evaluation of the structural integrity of their facilities." This and other individual FEMA Best Practices documents are also combined in "Mitigation Best Practices: Public and Private Sector Best Practice Stories for All Activity/Project Types in All States and Territories Relating to All Hazards [August 10, 2011]," which can be accessed at the following link: [https://www.hsdl.org/?abstract&did=683132]

Public Domain
Retrieved From:
Federal Emergency Management Agency (FEMA): http://www.fema.gov/
Media Type:
Help with citations